Equivalence test data for control drug to be submitted within two months after selection
Published: 2002-07-12 06:58:00
Updated: 2002-07-12 06:58:00
The Korea Food and Drug Administration (KFDA) announced that a drug manufacturer should submit to the necessary equivalence test data on control drug within two months after its selection and unless otherwise submitted, its notice will be cancelled, according to its envisioned draft.
The KFDA ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
